MX2007015471A - Amilasas para uso farmaceutico. - Google Patents
Amilasas para uso farmaceutico.Info
- Publication number
- MX2007015471A MX2007015471A MX2007015471A MX2007015471A MX2007015471A MX 2007015471 A MX2007015471 A MX 2007015471A MX 2007015471 A MX2007015471 A MX 2007015471A MX 2007015471 A MX2007015471 A MX 2007015471A MX 2007015471 A MX2007015471 A MX 2007015471A
- Authority
- MX
- Mexico
- Prior art keywords
- amylases
- bacillus
- improved
- pharmaceutical use
- seq
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
- C12N9/2411—Amylases
- C12N9/2414—Alpha-amylase (3.2.1.1.)
- C12N9/2417—Alpha-amylase (3.2.1.1.) from microbiological source
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/54—Mixtures of enzymes or proenzymes covered by more than a single one of groups A61K38/44 - A61K38/46 or A61K38/51 - A61K38/53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- General Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Diabetes (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
El uso farmaceutico de amilasas relacionadas con alfa amilasas de Bacillus de las SEQ ID NOs: 1-3, opcionalmente en combinacion con una lipasa y/o una proteasa. Los ejemplos de indicaciones medicas son: Tratamiento de trastornos digestivos, insuficiencia exocrina pancreatica (PEI), pancreatitis, fibrosis quistica, diabetes tipo I, y/o diabetes tipo II. Las amilasas de las SEQ ID NOs: 1-3 son variantes de las amilasas de Bacillus stearothermophilus, Bacilus licheniformis y Bacillus sp. Las amilasas de la invencion tienen una mejor eficacia in vivo, un mejor perfil de pH, una alta actividad especifica, y/o mejor perfil de degradacion de almidon.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA200500931 | 2005-06-24 | ||
PCT/DK2006/000354 WO2006136161A2 (en) | 2005-06-24 | 2006-06-16 | Amylases for pharmaceutical use |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2007015471A true MX2007015471A (es) | 2008-04-04 |
Family
ID=34956782
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2007015471A MX2007015471A (es) | 2005-06-24 | 2006-06-16 | Amilasas para uso farmaceutico. |
Country Status (15)
Country | Link |
---|---|
US (1) | US8017351B2 (es) |
EP (1) | EP1896057A2 (es) |
JP (1) | JP2008546396A (es) |
KR (1) | KR20080031868A (es) |
CN (1) | CN101242853A (es) |
AU (1) | AU2006261444A1 (es) |
BR (1) | BRPI0611932A2 (es) |
CA (1) | CA2612811A1 (es) |
IL (1) | IL187635A0 (es) |
MX (1) | MX2007015471A (es) |
NO (1) | NO20080439L (es) |
NZ (1) | NZ563737A (es) |
RU (1) | RU2008102650A (es) |
WO (1) | WO2006136161A2 (es) |
ZA (1) | ZA200710644B (es) |
Families Citing this family (84)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2440249T3 (es) * | 2006-04-04 | 2014-01-28 | Novozymes A/S | Proceso de trituración |
BRPI0721103A2 (pt) | 2006-12-21 | 2014-03-04 | Novozymes As | Lipase, método de determinação do desempenho da digestão in vitro de uma lipase em comparação com uma lipase de referência, uso de uma lipase ou de uma mistura de lipases, composição farmacêutica, e, método para o tratamento de doença |
CN101889084A (zh) | 2007-12-04 | 2010-11-17 | 诺维信公司 | 供药学应用的蛋白酶变体 |
GB2468629B (en) * | 2008-06-08 | 2011-10-26 | Tarig Sayed Mustafa Arbab | Method, composition, device for the treatment of amylase malfunctions/inactivity in association with saccharides (mainly polysaccharides) based diseases |
CN102438599B (zh) * | 2009-03-04 | 2015-01-21 | 迈雅营养品有限公司 | 通过降低血糖水平来控制糖尿病的营养组合物和方法 |
WO2011000924A1 (en) | 2009-07-03 | 2011-01-06 | Abbott Products Gmbh | Spray-dried amylase, pharmaceutical preparations comprising the same and use |
MX349630B (es) | 2010-01-04 | 2017-08-07 | Novozymes As | Alfa-amilasas. |
US8268305B1 (en) | 2011-09-23 | 2012-09-18 | Bio-Cat, Inc. | Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase |
US20130273026A1 (en) * | 2012-04-12 | 2013-10-17 | Integrative Enzymatics, Inc. | Composition and method for modulating inflammatory molecules with amylase |
WO2014194117A2 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
DK3110833T3 (da) | 2013-05-29 | 2020-04-06 | Danisco Us Inc | Hidtil ukendte metalloproteaser |
WO2014194032A1 (en) | 2013-05-29 | 2014-12-04 | Danisco Us Inc. | Novel metalloproteases |
EP3260538B1 (en) | 2013-05-29 | 2021-04-14 | Danisco US Inc. | Novel metalloproteases |
DK3553173T3 (da) | 2013-12-13 | 2021-08-23 | Danisco Us Inc | Serinproteaser af bacillus gibsonii-clade |
DK3080262T3 (da) | 2013-12-13 | 2019-05-06 | Danisco Us Inc | Serinproteaser af bacillus-arter |
EP3083704B1 (en) | 2013-12-16 | 2022-08-17 | Nutrition & Biosciences USA 4, Inc. | Use of poly alpha-1,3-glucan ethers as viscosity modifiers |
BR112016014014B1 (pt) | 2013-12-18 | 2021-08-10 | Nutrition & Biosciences USA 4, Inc. | Composição, método para a produção de um composto e método para o tratamento de um material |
US20150232785A1 (en) | 2014-02-14 | 2015-08-20 | E I Du Pont De Nemours And Company | Polysaccharides for viscosity modification |
CN103789285B (zh) * | 2014-02-19 | 2016-01-20 | 江南大学 | 一种热稳定性提高的淀粉酶突变体及其构建方法和应用 |
US9695253B2 (en) | 2014-03-11 | 2017-07-04 | E I Du Pont De Nemours And Company | Oxidized poly alpha-1,3-glucan |
EP4155398A1 (en) | 2014-03-21 | 2023-03-29 | Danisco US Inc. | Serine proteases of bacillus species |
WO2015162038A1 (en) * | 2014-04-25 | 2015-10-29 | Basf Se | Amylase variants |
WO2015195777A1 (en) | 2014-06-19 | 2015-12-23 | E. I. Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
US9714403B2 (en) | 2014-06-19 | 2017-07-25 | E I Du Pont De Nemours And Company | Compositions containing one or more poly alpha-1,3-glucan ether compounds |
WO2016036834A1 (en) * | 2014-09-02 | 2016-03-10 | Danisco Us Inc. | Dp5-enriched syrups |
CN104212780A (zh) * | 2014-09-02 | 2014-12-17 | 华东理工大学 | 一种α-淀粉酶及其编码基因与应用 |
WO2016061438A1 (en) | 2014-10-17 | 2016-04-21 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069557A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases of bacillus species |
WO2016069569A2 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
WO2016069544A1 (en) | 2014-10-27 | 2016-05-06 | Danisco Us Inc. | Serine proteases |
US20170335306A1 (en) | 2014-10-27 | 2017-11-23 | Danisco Us Inc. | Serine proteases |
DK3212662T3 (da) | 2014-10-27 | 2020-07-20 | Danisco Us Inc | Serinproteaser |
US10131929B2 (en) | 2014-12-23 | 2018-11-20 | E. I. Du Pont De Nemours And Company | Enzymatically produced cellulose |
RU2733987C2 (ru) | 2015-05-13 | 2020-10-09 | ДАНИСКО ЮЭс ИНК. | Варианты протеазы клады aprl и их применения |
WO2016201040A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc. | Water-triggered enzyme suspension |
FI3307427T3 (fi) | 2015-06-09 | 2023-11-09 | Danisco Us Inc | Osmoottiset puhkeavat kapselit |
WO2016201069A1 (en) | 2015-06-09 | 2016-12-15 | Danisco Us Inc | Low-density enzyme-containing particles |
CN107849549B (zh) | 2015-06-17 | 2024-04-05 | 丹尼斯科美国公司 | 吉氏芽孢杆菌进化枝丝氨酸蛋白酶 |
WO2017052455A1 (en) | 2015-09-23 | 2017-03-30 | Anara Ab | Amylase fragments for blood glucose control |
BR112018008946A2 (pt) | 2015-11-05 | 2020-11-03 | Danisco Us Inc. | mananases de paenibacillus sp. |
US20180320158A1 (en) | 2015-11-05 | 2018-11-08 | Danisco Us Inc. | Paenibacillus and bacillus spp. mannanases |
WO2017083226A1 (en) | 2015-11-13 | 2017-05-18 | E. I. Du Pont De Nemours And Company | Glucan fiber compositions for use in laundry care and fabric care |
EP3374400B1 (en) | 2015-11-13 | 2022-04-13 | Nutrition & Biosciences USA 4, Inc. | Glucan fiber compositions for use in laundry care and fabric care |
JP2019504932A (ja) | 2015-11-13 | 2019-02-21 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニーE.I.Du Pont De Nemours And Company | 洗濯ケアおよび織物ケアにおいて使用するためのグルカン繊維組成物 |
WO2017100720A1 (en) | 2015-12-09 | 2017-06-15 | Danisco Us Inc. | Alpha-amylase combinatorial variants |
WO2017106676A1 (en) | 2015-12-18 | 2017-06-22 | Danisco Us Inc | Polypeptides with endoglucanase activity and uses thereof |
CN109715791B (zh) | 2016-05-03 | 2023-07-14 | 丹尼斯科美国公司 | 蛋白酶变体及其用途 |
CN109415421B (zh) * | 2016-05-03 | 2023-02-28 | 诺维信公司 | α-淀粉酶变体以及编码它们的多核苷酸 |
US20190136218A1 (en) | 2016-05-05 | 2019-05-09 | Danisco Us Inc | Protease variants and uses thereof |
US11661567B2 (en) | 2016-05-31 | 2023-05-30 | Danisco Us Inc. | Protease variants and uses thereof |
EP3251687A1 (en) | 2016-06-01 | 2017-12-06 | Centrum Innowacji Edoradca Sp. z o.o. Spolka Komandytowa | Bioactive peptides for blood glucose control |
MX2018015559A (es) | 2016-06-17 | 2019-06-06 | Danisco Us Inc | Variantes de proteasa y sus usos. |
GB201614415D0 (en) | 2016-08-24 | 2016-10-05 | Pepsis Ltd | Enzymes for the treatment of human enterometabolic dysfunction |
EP3535365A2 (en) | 2016-11-07 | 2019-09-11 | Danisco US Inc. | Laundry detergent composition |
WO2018118917A1 (en) | 2016-12-21 | 2018-06-28 | Danisco Us Inc. | Protease variants and uses thereof |
CN110312794B (zh) | 2016-12-21 | 2024-04-12 | 丹尼斯科美国公司 | 吉氏芽孢杆菌进化枝丝氨酸蛋白酶 |
WO2018169750A1 (en) | 2017-03-15 | 2018-09-20 | Danisco Us Inc | Trypsin-like serine proteases and uses thereof |
US20200040283A1 (en) | 2017-03-31 | 2020-02-06 | Danisco Us Inc | Delayed release enzyme formulations for bleach-containing detergents |
WO2019006077A1 (en) | 2017-06-30 | 2019-01-03 | Danisco Us Inc | PARTICLES CONTAINING LOW AGGLOMERATION ENZYME |
CN111373039A (zh) | 2017-11-29 | 2020-07-03 | 丹尼斯科美国公司 | 具有改善的稳定性的枯草杆菌蛋白酶变体 |
CA3086202A1 (en) | 2017-12-21 | 2019-06-27 | Danisco Us Inc. | Enzyme-containing, hot-melt granules comprising a thermotolerant desiccant |
CN111867388A (zh) | 2018-02-08 | 2020-10-30 | 丹尼斯科美国公司 | 用于酶包封的耐热蜡基质颗粒 |
US11690392B2 (en) | 2018-04-18 | 2023-07-04 | Baylor College Of Medicine | Development of amyloglucosidase as a medicinal food or dietary supplement |
US20210363470A1 (en) | 2018-06-19 | 2021-11-25 | Danisco Us Inc | Subtilisin variants |
US20210214703A1 (en) | 2018-06-19 | 2021-07-15 | Danisco Us Inc | Subtilisin variants |
EP3844255A1 (en) | 2018-08-30 | 2021-07-07 | Danisco US Inc. | Enzyme-containing granules |
JP2022503923A (ja) | 2018-09-27 | 2022-01-12 | ダニスコ・ユーエス・インク | 医療用器具を洗浄するための組成物 |
EP3887515A1 (en) | 2018-11-28 | 2021-10-06 | Danisco US Inc. | Subtilisin variants having improved stability |
CN114174504A (zh) | 2019-05-24 | 2022-03-11 | 丹尼斯科美国公司 | 枯草杆菌蛋白酶变体和使用方法 |
WO2020247582A1 (en) | 2019-06-06 | 2020-12-10 | Danisco Us Inc | Methods and compositions for cleaning |
CN116323935A (zh) | 2020-08-27 | 2023-06-23 | 丹尼斯科美国公司 | 用于清洁的酶和酶组合物 |
EP4284906A1 (en) | 2021-01-29 | 2023-12-06 | Danisco US Inc. | Compositions for cleaning and methods related thereto |
CN117616120A (zh) | 2021-06-30 | 2024-02-27 | 丹尼斯科美国公司 | 变体脂肪酶及其用途 |
EP4396320A2 (en) | 2021-09-03 | 2024-07-10 | Danisco US Inc. | Laundry compositions for cleaning |
WO2023039270A2 (en) | 2021-09-13 | 2023-03-16 | Danisco Us Inc. | Bioactive-containing granules |
WO2023114936A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114932A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023114939A2 (en) | 2021-12-16 | 2023-06-22 | Danisco Us Inc. | Subtilisin variants and methods of use |
WO2023168234A1 (en) | 2022-03-01 | 2023-09-07 | Danisco Us Inc. | Enzymes and enzyme compositions for cleaning |
WO2023250301A1 (en) | 2022-06-21 | 2023-12-28 | Danisco Us Inc. | Methods and compositions for cleaning comprising a polypeptide having thermolysin activity |
WO2024050343A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Subtilisin variants and methods related thereto |
WO2024050346A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Detergent compositions and methods related thereto |
WO2024050339A1 (en) | 2022-09-02 | 2024-03-07 | Danisco Us Inc. | Mannanase variants and methods of use |
WO2024102698A1 (en) | 2022-11-09 | 2024-05-16 | Danisco Us Inc. | Subtilisin variants and methods of use |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK173590D0 (da) | 1990-06-06 | 1990-07-19 | Novo Nordisk As | Rekombinante terapeutiske lipaser |
US5281526A (en) * | 1992-10-20 | 1994-01-25 | Solvay Enzymes, Inc. | Method of purification of amylase by precipitation with a metal halide and 4-hydroxybenzic acid or a derivative thereof |
EP0828509B1 (en) | 1995-05-31 | 2005-01-26 | Medzyme N.V. | Composition to improve digestibility and utilisation of nutrients |
ES2432519T3 (es) * | 1996-04-30 | 2013-12-04 | Novozymes A/S | Mutantes de alfa-amilasa |
JP4358431B2 (ja) | 1997-10-13 | 2009-11-04 | ノボザイムス アクティーゼルスカブ | α−アミラーゼ変異体 |
TR200102784T2 (tr) * | 1999-03-17 | 2002-04-22 | Solvay Pharmaceuticals Gmbh | Diyabet tedavisi için ilaç |
US6410295B1 (en) * | 1999-03-30 | 2002-06-25 | Novozymes A/S | Alpha-amylase variants |
US20010046493A1 (en) | 2000-02-24 | 2001-11-29 | Alex Margolin | Lipase-containing composition and methods of use thereof |
AR032392A1 (es) * | 2001-01-19 | 2003-11-05 | Solvay Pharm Gmbh | Mezcla de enzimas, preparado farmaceutico y utilizacion de dicho preparado. |
RU2201763C1 (ru) | 2001-12-29 | 2003-04-10 | Закрытое акционерное общество "Брынцалов-А" | Полиферментное средство ферестал |
DE10260903A1 (de) * | 2002-12-20 | 2004-07-08 | Henkel Kgaa | Neue Perhydrolasen |
WO2004078960A1 (en) | 2003-02-26 | 2004-09-16 | Genencor International, Inc. | Amylases producing an altered immunogenic response and methods of making and using the same |
EP1896577A2 (en) * | 2005-06-24 | 2008-03-12 | Novozymes A/S | Lipases for pharmaceutical use |
EP1896058A2 (en) * | 2005-06-24 | 2008-03-12 | Novozymes A/S | Proteases for pharmaceutical use |
-
2006
- 2006-06-16 US US11/917,551 patent/US8017351B2/en not_active Expired - Fee Related
- 2006-06-16 BR BRPI0611932-8A patent/BRPI0611932A2/pt not_active IP Right Cessation
- 2006-06-16 WO PCT/DK2006/000354 patent/WO2006136161A2/en active Application Filing
- 2006-06-16 NZ NZ563737A patent/NZ563737A/en not_active IP Right Cessation
- 2006-06-16 EP EP06742473A patent/EP1896057A2/en not_active Withdrawn
- 2006-06-16 JP JP2008517320A patent/JP2008546396A/ja active Pending
- 2006-06-16 AU AU2006261444A patent/AU2006261444A1/en not_active Abandoned
- 2006-06-16 CA CA002612811A patent/CA2612811A1/en not_active Abandoned
- 2006-06-16 RU RU2008102650/13A patent/RU2008102650A/ru not_active Application Discontinuation
- 2006-06-16 KR KR1020077029681A patent/KR20080031868A/ko not_active Application Discontinuation
- 2006-06-16 MX MX2007015471A patent/MX2007015471A/es not_active Application Discontinuation
- 2006-06-16 CN CNA2006800302221A patent/CN101242853A/zh active Pending
-
2007
- 2007-11-26 IL IL187635A patent/IL187635A0/en unknown
- 2007-12-06 ZA ZA200710644A patent/ZA200710644B/xx unknown
-
2008
- 2008-01-23 NO NO20080439A patent/NO20080439L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2008102650A (ru) | 2009-07-27 |
CA2612811A1 (en) | 2006-12-28 |
IL187635A0 (en) | 2008-03-20 |
US8017351B2 (en) | 2011-09-13 |
US20090035293A1 (en) | 2009-02-05 |
WO2006136161A2 (en) | 2006-12-28 |
AU2006261444A1 (en) | 2006-12-28 |
WO2006136161A3 (en) | 2007-07-05 |
NO20080439L (no) | 2008-03-04 |
BRPI0611932A2 (pt) | 2011-01-04 |
EP1896057A2 (en) | 2008-03-12 |
KR20080031868A (ko) | 2008-04-11 |
CN101242853A (zh) | 2008-08-13 |
NZ563737A (en) | 2010-08-27 |
JP2008546396A (ja) | 2008-12-25 |
ZA200710644B (en) | 2008-11-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2007015471A (es) | Amilasas para uso farmaceutico. | |
DK1755656T3 (da) | Enzymer til farmaceutisk anvendelse | |
NO20080437L (no) | Lipaser til farmasoytisk anvendelse | |
MX2007015474A (es) | Proteasas para uso farmaceutico. | |
MX2010005690A (es) | Variantes de proteasa para uso farmaceutico. | |
NO20092729L (no) | Lipasevarianter for farmasoytisk anvendelse | |
IL209979A (en) | Use of 70 hsp to prepare a drug to treat lysosomal storage disease | |
WO2005111203A3 (en) | MUTANT α ΑMYLASES | |
AU2011270668A8 (en) | CNS delivery of therapeutic agents | |
WO2011063394A3 (en) | Compositions and methods comprising serratia peptidase for inhibition and treatment of biofilms related to certain conditions | |
GB2511713A (en) | Methods of treating behavioral symptoms of neurological and mental disorders | |
MX2009009378A (es) | Variantes de alfa-amilasa de especies de bacillus alcalifilico, composiciones que comprenden las variantes de alfa-amilasa, y metodos de uso. | |
MX2013000321A (es) | Suministro al sistema nervioso central de agentes terapeuticos. | |
MX2010007846A (es) | Fabricación de enzimas sulfatasa lisosomal humana altamente fosforilada, activa y usos de las mismas. | |
JP2008521906A5 (es) | ||
WO2001097829A3 (en) | Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases | |
NZ595193A (en) | Modified Proteases That Inhibit Complement Activation | |
WO2003086452A3 (en) | Methods of enhancing lysosomal storage disease therapy | |
PT1162995E (pt) | Enzimas para o tratamento da diabetes mellitus do tipo i | |
MX2007012324A (es) | Dispositivo y metodo para tratar condiciones del seno paranasal. | |
GB201320527D0 (en) | Enzyme delivery systems and methods of preparations and use | |
WO2009100138A3 (en) | Variants of bacillus stearothermophilus alpha-amylase and uses thereof | |
MY161843A (en) | Pancreatic enzyme compositions and methods for treating pancreatitis and pancreatic insufficiency | |
NZ595364A (en) | TISSUE KALLIKREIN FOR THE TREATMENT OF PANCREATIC beta-CELL DYSFUNCTION | |
WO2006060051A3 (en) | Enzyme chimeras and methods of their use for the treatment of infection by bacillus anthracis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |